{"entity":{"id":"neuro-oncology","kind":"journal","name":"Neuro-Oncology","aka":["Neuro Oncol"],"tldr":"Neuro-Oncology is the Society for Neuro-Oncology's journal, publishing glioma, brain metastasis and paediatric brain tumour research, response criteria and the CBTRUS statistical reports.","summary":"Publishes the annual CBTRUS statistical report on US brain tumours, the RANO response-assessment criteria, molecular classification work that feeds the WHO CNS tumour classification, and phase 2 trials in glioma. Hybrid access via Oxford University Press; the SNO annual meeting abstracts appear as a supplement.","asOf":"2026-09-09","links":[{"label":"Society for Neuro-Oncology","url":"https://www.soc-neuro-onc.org"}],"tags":[],"related":[],"cancers":["glioblastoma"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"publisher":"Oxford University Press","url":"https://academic.oup.com/neuro-oncology","issn":"1522-8517","scope":"neuro-oncology","access":"hybrid","founded":1999,"impactFactor":{"value":16.4,"year":2023,"source":"Clarivate Journal Citation Reports 2024 (2023 JIF)"},"matchNames":["Neuro-Oncology","Neuro Oncol","Neuro-oncology"],"society":"Society for Neuro-Oncology"},"route":"/journals/neuro-oncology/","neighbours":{"cancer":[{"id":"glioblastoma","kind":"cancer","name":"Glioma & glioblastoma","route":"/cancers/glioblastoma/"}],"person":[{"id":"patrick-wen","kind":"person","name":"Patrick Y. Wen","route":"/people/patrick-wen/"}],"paper":[{"id":"paper-carboplatin-glioblastoma-neuro-oncol-2003","kind":"paper","name":"A randomized, double-blind, placebo-controlled, phase 2 study of RMP-7 in combination with carboplatin administered intravenously for the treatment of recurrent malignant glioma","route":"/key-papers/paper-carboplatin-glioblastoma-neuro-oncol-2003/"},{"id":"paper-acns1123-germinoma-neuro-oncology-2022","kind":"paper","name":"ACNS1123: response-based reduced-dose whole-ventricular radiotherapy for localised germinoma","route":"/key-papers/paper-acns1123-germinoma-neuro-oncology-2022/"},{"id":"paper-fruhwald-neuro-oncol","kind":"paper","name":"Age and DNA methylation subgroup as potential independent risk factors for treatment stratification in children with atypical teratoid/rhabdoid tumors","route":"/key-papers/paper-fruhwald-neuro-oncol/"},{"id":"paper-eano-meningioma-goldbrunner-neuro-oncology-2021","kind":"paper","name":"EANO guideline on the diagnosis and management of meningiomas (2021)","route":"/key-papers/paper-eano-meningioma-goldbrunner-neuro-oncology-2021/"},{"id":"paper-andrew-lassman-neuro-oncol-2020","kind":"paper","name":"Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions","route":"/key-papers/paper-andrew-lassman-neuro-oncol-2020/"},{"id":"paper-lim-neuro-oncol","kind":"paper","name":"Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated MGMT promoter","route":"/key-papers/paper-lim-neuro-oncol/"},{"id":"paper-karschnia-neuro-oncol","kind":"paper","name":"Prognostic validation of a new classification system for extent of resection in glioblastoma: A report of the RANO resect group","route":"/key-papers/paper-karschnia-neuro-oncol/"},{"id":"paper-omuro-neuro-oncol","kind":"paper","name":"Radiotherapy combined with nivolumab or temozolomide for newly diagnosed glioblastoma with unmethylated MGMT promoter: An international randomized phase III trial","route":"/key-papers/paper-omuro-neuro-oncol/"},{"id":"paper-carboplatin-glioblastoma-neuro-oncol-2015","kind":"paper","name":"Randomized phase 2 study of carboplatin and bevacizumab in recurrent glioblastoma","route":"/key-papers/paper-carboplatin-glioblastoma-neuro-oncol-2015/"},{"id":"paper-siop-cns-gct-96-calaminus-neuro-oncology-2013","kind":"paper","name":"SIOP CNS GCT 96: outcomes for children and adults with intracranial germinoma treated with radiotherapy alone or chemotherapy plus reduced radiotherapy","route":"/key-papers/paper-siop-cns-gct-96-calaminus-neuro-oncology-2013/"},{"id":"paper-who-2021-cns-louis-neuro-oncology-2021","kind":"paper","name":"The 2021 WHO classification of tumours of the central nervous system: a summary","route":"/key-papers/paper-who-2021-cns-louis-neuro-oncology-2021/"}],"journal":[{"id":"journal-of-neuro-oncology","kind":"journal","name":"Journal of neuro-oncology","route":"/journals/journal-of-neuro-oncology/"}]}}